Expert Outlook: Exact Sciences Through The Eyes Of 5 Analysts

Jun 26, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Exact Sciences, presenting an average target of $83.0, a high estimate of $100.00, and a low …

CouponFollow Extension

$83
OFF

Expert Outlook: Exact Sciences Through The Eyes Of 5 Analysts

1 day from now

Jun 26, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Exact Sciences, presenting an average target of $83.0, a high estimate of $100.00, and a low …

businessinsider.com

$88
OFF

A Glimpse Into The Expert Outlook On Exact Sciences Through 5 …

1 day from now

Jan 2, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Exact Sciences, presenting an average target of $88.2, a high estimate of $91.00, and a low …

businessinsider.com

$88
OFF

A Glimpse Into The Expert Outlook On Exact Sciences Through 5 …

1 day from now

Jan 2, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Exact Sciences, presenting an average target of $88.2, a high estimate of $91.00, and a low …

sahmcapital.com

$22
OFF

Expert Outlook: MARA Holdings Through The Eyes Of 5 Analysts

1 day from now

Nov 13, 2024 · The 12-month price targets, analyzed by analysts, offer insights with an average target of $22.0, a high estimate of $28.00, and a low estimate of $12.00.

benzinga.com

$7
OFF

Expert Outlook: Fastly Through The Eyes Of 5 Analysts

1 day from now

Aug 27, 2024 · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $7.4, a high estimate of $10.00, and a low estimate of $6.00.

nasdaq.com

$8
OFF

Expert Outlook: CytoSorbents Through The Eyes Of 5 Analysts

1 day from now

Oct 22, 2024 · Insights from analysts' 12-month price targets are revealed, presenting an average target of $8.2, a high estimate of $10.00, and a low estimate of $1.00.

nasdaq.com

$83
OFF

Expert Outlook: Exact Sciences Through The Eyes Of 5 Analysts

1 day from now

Jun 27, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Exact Sciences, presenting an average target of $83.0, a high estimate of $100.00, and a low …

hstong.com

$29
OFF

Expert Outlook: Liquidia Through The Eyes Of 5 Analysts

1 day from now

Jul 18, 2024 · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $29.6, a high estimate of $32.00, and a low estimate of …

nasdaq.com

$24
OFF

Expert Outlook: Excelerate Energy Through The Eyes Of 5 Analysts

1 day from now

Nov 11, 2024 · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $24.6, along with a high estimate of $29.00 and a low estimate …

nasdaq.com

FAQs about Expert Outlook: Exact Sciences Through The Eyes Of 5 Analysts Coupon?

What's going on with Exact Sciences (Exact Sciences) price targets?

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. In the assessment of 12-month price targets, analysts unveil insights for Exact Sciences, presenting an average target of $83.0, a high estimate of $100.00, and a low estimate of $70.00. ...

How do analysts evaluate Exact Sciences (Exact Sciences) stock?

Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Exact Sciences compared to the broader market. Price Targets: Analysts set price targets as an estimate of a stock's future value. ...

Does exact sciences have an economic impact?

Exact Sciences's Economic Impact: An Analysis Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale. ...

Is exact sciences a good stock to buy?

Net Margin: Exact Sciences's net margin excels beyond industry benchmarks, reaching -2.26%. This signifies efficient cost management and strong financial health. Return on Equity (ROE): Exact Sciences's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. ...

How did exact sciences perform compared to other health care companies?

As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector. Net Margin: Exact Sciences's net margin surpasses industry standards, highlighting the company's exceptional financial performance. ...

Who makes exact tests?

About Exact Sciences Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. ...